| Literature DB >> 34955097 |
Thies Ingwersen1, Silke Wolf2, Gunnar Birke2, Eckhard Schlemm2, Christian Bartling3, Gabriele Bender4, Alfons Meyer3, Achim Nolte5, Katharina Ottes4, Oliver Pade6, Martin Peller7, Jochen Steinmetz6, Christian Gerloff2, Götz Thomalla2.
Abstract
BACKGROUND: Impaired motor functions after stroke are common and negatively affect patients' activities of daily living and quality of life. In particular, hand motor function is essential for daily activities, but often returns slowly and incompletely after stroke. However, few data are available on the long-term dynamics of motor recovery and self-reported health status after stroke. The Interdisciplinary Platform for Rehabilitation Research and Innovative Care of Stroke Patients (IMPROVE) project aims to address this knowledge gap by studying the clinical course of recovery after inpatient rehabilitation.Entities:
Keywords: Neurological rehabilitation; Patient outcome assessment; Recovery of function; Stroke; Upper extremity
Year: 2021 PMID: 34955097 PMCID: PMC8711154 DOI: 10.1186/s42466-021-00164-7
Source DB: PubMed Journal: Neurol Res Pract ISSN: 2524-3489
Fig. 1Flow-chart of participants in the IMPROVE study
Demographic and clinical patient characteristics at baseline
| Demographic characteristics | |
| Female | 42 (24) |
| Age | 59 (52–64) |
| Stroke type | |
| ischemic | 160 (91) |
| hemorrhagic | 16 (9) |
| Clinical characteristics | |
| Arm paresis | 118 (73) |
| NIHSS | 2 (1–4) |
| mRS | 1 (1–2) |
| Thrombolysis | 32 (19) |
| Thrombectomy | 13 (8) |
| Craniectomy | 5 (3) |
| Cardiovascular risk factors | |
| Hypertention | 140 (80) |
| Hyperlipidemia | 112 (68) |
| Diabetes mellitus | 31 (18) |
| Atrial fibrillation | 15 (11) |
| Overweight | 77 (44) |
| Nicotine abuse | 89 (51) |
| Alcohol abuse | 16 (9) |
Values are expressed as number (percent) or median (interquartile range). NIHSS: National Institutes of Health Stroke Scale, mRS: modified Rankin Scale
Fig. 2Progress of motor function recovery up to 1 year of follow up. The absolute values (upper row) and the changes (lower row) in respect to baseline (T0) are depicted for the motor function assessments FMA (A, E), grip strength ratio (B, F), pinch strength ratio (C, G) and NHPT ratio (D, H). Follow-up (FU) 1 to 3 was carried out three, six and twelve months after inclusion at the end of inpatient rehabilitation, respectively. Individual data points and box plots are reported for every follow up examination. The mean is indicated as a black rhombus
Fig. 3Progress of PROMIS-10 up to 1 year of follow up. The absolute values (upper row) and the changes (lower row) in respect to baseline (T0) are depicted for the physical domain (A, C) and mental domain (B, D). Follow-up (FU) 1 to 3 was carried out three, six and twelve months after inclusion at the end of inpatient rehabilitation, respectively. Individual data points and box plots are reported for every follow up examination. The mean is indicated as a black rhombus
Linear random coefficients models
| Intercept | Estimate | ||
|---|---|---|---|
| Motor function tests | |||
| Fugl-Meyer Assessment | 53.0 (50.7–55.3) | 5.0 (3.7–6.4) | < 0.001 |
| Grip strength ratio | 0.68 (0.63–0.73) | 0.07 (0.03–0.11) | < 0.001 |
| Pinch Strength Ratio | 0.75 (0.70–0.81) | 0.13 (0.09–0.17) | < 0.001 |
| Nine-Hole Peg Test Ratio | 0.74 (0.69–0.79) | 0.07 (0.04–0.1) | < 0.001 |
| PROMIS-10 | |||
| Physical domain | 44.2 (43.2–45.2) | 2.5 (1.4–3.6) | < 0.001 |
| Mental domain | 44.3 (43.3–45.4) | 2.4 (1.4–3.4) | < 0.001 |
Univariate models with time after inclusion in years as fixed effect. Numbers express values (95% confidence interval)
Mean change of motor function tests and PROMIS-10 over 12-months follow-up
| Baseline | 12-months follow-up | Delta | |
|---|---|---|---|
| Motor function tests | |||
| Fugl-Meyer Assessment | 52.7 (± 15.1) | 56.8 (± 13.5) | 4.1 |
| Grip Strength Ratio | 0.69 (± 0.34) | 0.75 (± 0.33) | 0.06 |
| Pinch Strength Ratio | 0.75 (± 0.36) | 0.87 (± 0.29) | 0.12 |
| Nine-Hole Peg Test Ratio | 0.73 (± 0.33) | 0.77 (± 0.31) | 0.04 |
| PROMIS-10 | |||
| Physical domain | 44.1 (± 7.0) | 46.7 (± 7.0) | 2.6 |
| Mental domain | 44.0 (± 7.4) | 46.3 (± 7.2) | 2.3 |
Mean (± standard deviation) is shown for baseline and 12-months follow-up. The mean change (delta) is calculated by subtracting 12-months follow-up values from baseline values
Group differences of improvers and non-improvers in the FMA hand score
| Total | Improver | Non-Improver | ||
|---|---|---|---|---|
| Demographic characteristics | ||||
| Female | 12 (24) | 6 (15) | 6 (55) | |
| Age | 59 (53–67) | 60 (50–65) | 59 (56–74) | 0.3187 |
| Clinical characteristics | ||||
| Ischemic stroke | 46 (92) | 37 (95) | 9 (82) | 0.2069 |
| Baseline NIHSS | 4 (2–6) | 4 (1.5–6) | 3 (2.25–4.75) | 0.6984 |
| Baseline mRS | 2 (1–2) | 2 (1–2) | 2 (1.5–2.5) | 0.3416 |
| Cardiovascular risk factors | ||||
| Hypertension | 42 (84) | 34 (87) | 8 (73) | 0.3533 |
| Hyperlipidemia | 37 (77) | 28 (76) | 9 (82) | 0.7136 |
| Diabetes mellitus | 12 (24) | 10 (26) | 2 (18) | 0.7351 |
| Atrial fibrillation | 2 (5) | 2 (7) | 0 (0) | 1 |
| Overweight | 20 (40) | 16 (41) | 4 (36) | 1 |
| Nicotine abuse | 21 (43) | 17 (44) | 4 (40) | 1 |
| Alcohol abuse | 5 (10) | 4 (10) | 1 (9) | 1 |
| MoCA (at inclusion) | 25 (22–27) | 25 (23–27) | 22 (20.5–24) | |
| IMET (at inclusion) | 35 (24.75–52) | 31 (22.5–51) | 50 (35–52) | 0.1805 |
| PHQ4 (at inclusion) | 3 (1–4) | 2.5 (0.25–4) | 3 (2–4) | 0.6185 |
| Motor therapy duration | 46.7 (9–100.4) | 48.3 (17.5–101.3) | 26.7 (1.7–74.4) | 0.3204 |
| PROMIS-10 (at inclusion) | ||||
| Physical domain | 42.3 (39.8–47.7) | 42.3 (39.8–47.7) | 42.3 (38.6–44.9) | 0.6190 |
| Mental domain | 43.5 (41.1–45.8) | 43.5 (41.1–47.68) | 41.1 (38.8–44.65) | 0.1446 |
NIHSS: National Institutes of Health Stroke Scale, mRS: modified Rankin Scale, MoCA: Montreal Cognitive Assessment, IMET: Index for the Assessment of Health Impairments, PHQ4: Patient Health Questionnaire-4, Motor therapy duration: Mean weekly minutes of physio- or ergotherapy across all follow-ups. Values are reported as numbers (percent) or median (interquartile range) where applicable. Significant p values are displayed in bold